Latest News about ASND
Recent news which mentions ASND
Oppenheimer Maintains Outperform Rating for Ascendis Pharma: Here's What You Need To Know
August 11, 2022
Tickers
ASND
From Benzinga
From Benzinga
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 14, 2022
From Benzinga
10 Biggest Price Target Changes For Monday
March 14, 2022
From Benzinga
7 Biotech Stocks With Key Catalysts in March
March 09, 2022
From InvestorPlace
From Benzinga
Earnings Scheduled For March 2, 2022
March 02, 2022
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2022
February 14, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2022
January 06, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021
December 08, 2021
From Benzinga
The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial
November 19, 2021
From Benzinga
Ascendis' Hypoparathyroidism Candidate Shows Durable Benefit At 84 Weeks
November 19, 2021
Tickers
ASND
From Benzinga
10 Biggest Price Target Changes For Monday
November 15, 2021
From Benzinga
Ascendis Pharma A/S (ASND) Q3 2021 Earnings Call Transcript
November 10, 2021
Tickers
ASND
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2021
October 20, 2021
From Benzinga
This Growth Hormone Drug Could Be a Boost For Pfizer
October 05, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.